Question

A 58-year-old with new AF and CHA₂DS₂-VASc 1 (male, hypertension only) asks about anticoagulation. What does the 2023 guideline suggest?

Accepted Answer

Anticoagulation is reasonable but not mandatory at annual risk 1-2% (≈ CHA₂DS₂-VASc 1 in men)

Answer

Anticoagulation is class I at CHA₂DS₂-VASc 1 in men

Answer

Aspirin monotherapy is preferred

Answer

No antithrombotic therapy allowed

Answer

Dual antiplatelet therapy preferred

Practice question

A 58-year-old with new AF and CHA₂DS₂-VASc 1 (male, hypertension only) asks about anticoagulation. What does the 2023 guideline suggest?